European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012  M. Tvede,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-C. Lagier  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection  S.B.
Varicella vaccination: a laboured take-off
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis  J.
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics  Y.H. van Beurden, S. Nezami,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors  S.B. Debast, N. Vaessen, A. Choudry,
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
E. Bouza  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
E. Bouza, P. Muñoz, R. Alonso  Clinical Microbiology and Infection 
Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients  S. Erb, R. Frei,
Training for the infectious diseases speciality in Norway
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Laboratory diagnosis and biosafety issues of biological warfare agents
M.H. Wilcox  Clinical Microbiology and Infection 
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study  E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
L. Fenner, A. F. Widmer, A. Stranden, M. Conzelmann, A. Goorhuis, C
Mathematical modeling of Clostridium difficile infection
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection  M.J.T.
The practice of travel medicine in Europe
F. Blasi, P. Palange, G. Rohde, T. Severin, G. Cornaglia, R. Finch 
The role of antimalarial treatment in the elimination of malaria
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
P.M. Hawkey  Clinical Microbiology and Infection 
Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.
Training in infectious diseases and tropical medicine in Britain
Current experience in treating invasive zygomycosis with posaconazole
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Microbiologic factors affecting Clostridium difficile recurrence
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study  M.P.M. Hensgens, O.M.
C.P. Kelly  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Typing of Clostridium difficile
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI)  M.J.T. Crobach, O.M. Dekkers, M.H. Wilcox, E.J. Kuijper  Clinical Microbiology and Infection  Volume 15, Issue 12, Pages 1053-1066 (December 2009) DOI: 10.1111/j.1469-0691.2009.03098.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Summary of selection process. Clinical Microbiology and Infection 2009 15, 1053-1066DOI: (10.1111/j.1469-0691.2009.03098.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Algorithm to diagnose CDI Clinical Microbiology and Infection 2009 15, 1053-1066DOI: (10.1111/j.1469-0691.2009.03098.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Application of two-step algorithm in a population of 1000 patients with a CDI prevalence 5%. Clinical Microbiology and Infection 2009 15, 1053-1066DOI: (10.1111/j.1469-0691.2009.03098.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions